Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells.
Avedissian SN, Malik JR, Podany AT, Neely M, Rhodes NJ, Scarsi KK, Scheetz MH, Duryee MJ, Modebelu UO, Mykris TM, Winchester LC, Byrareddy SN, Fletcher CV. Avedissian SN, et al. Among authors: byrareddy sn. Sci Rep. 2024 May 10;14(1):10709. doi: 10.1038/s41598-024-60935-5. Sci Rep. 2024. PMID: 38729980 Free PMC article.
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
Pandey K, Acharya A, Pal D, Jain P, Singh K, Durden DL, Kutateladze TG, Deshpande AJ, Byrareddy SN. Pandey K, et al. Among authors: byrareddy sn. Antiviral Res. 2024 May 8;227:105904. doi: 10.1016/j.antiviral.2024.105904. Online ahead of print. Antiviral Res. 2024. PMID: 38729306
Emergence of SARS-CoV-2 Omicron Variant JN.1 in Tamil Nadu, India - Clinical Characteristics and Novel Mutations.
Selvavinayagam ST, Sankar S, Yong YK, Murugesan A, Suvaithenamudhan S, Hemashree K, Rajeshkumar M, Kumaresan A, Pandey RP, Shanmugam S, Arthydevi P, Kumar MS, Gopalan N, Kannan M, Cheedarla N, Tan HY, Zhang Y, Larsson M, Balakrishnan P, Velu V, Byrareddy SN, Shankar EM, Raju S. Selvavinayagam ST, et al. Among authors: byrareddy sn. medRxiv [Preprint]. 2024 Apr 19:2024.04.16.24305882. doi: 10.1101/2024.04.16.24305882. medRxiv. 2024. PMID: 38699322 Free PMC article. Preprint.
Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study.
Selvavinayagam ST, Suvaithenamudhan S, Yong YK, Hemashree K, Rajeshkumar M, Kumaresan A, Arthydevi P, Kannan M, Gopalan N, Vignesh R, Murugesan A, Sivasankaran MP, Sankar S, Cheedarla N, Anshad AR, Govindaraj S, Zhang Y, Tan HY, Larsson M, Saravanan S, Balakrishnan P, Kulanthaivel L, Singh K, Joseph N, Velu V, Byrareddy SN, Shankar EM, Raju S. Selvavinayagam ST, et al. Among authors: byrareddy sn. J Med Virol. 2024 Feb;96(2):e29456. doi: 10.1002/jmv.29456. J Med Virol. 2024. PMID: 38329187
Islatravir: evaluation of clinical development for HIV and HBV.
Gillespie SW, Reddy AS, Burris DM, Naqvi SH, Byrareddy SN, Lorson CL, Singh K. Gillespie SW, et al. Among authors: byrareddy sn. Expert Opin Investig Drugs. 2024 Feb;33(2):85-93. doi: 10.1080/13543784.2024.2305130. Epub 2024 Jan 26. Expert Opin Investig Drugs. 2024. PMID: 38235744
Clinical characteristics and novel mutations of omicron subvariant XBB in Tamil Nadu, India - a cohort study.
Selvavinayagam ST, Karishma SJ, Hemashree K, Yong YK, Suvaithenamudhan S, Rajeshkumar M, Aswathy B, Kalaivani V, Priyanka J, Kumaresan A, Kannan M, Gopalan N, Chandramathi S, Vignesh R, Murugesan A, Anshad AR, Ganesh B, Joseph N, Babu H, Govindaraj S, Larsson M, Kandasamy SL, Palani S, Singh K, Byrareddy SN, Velu V, Shankar EM, Raju S. Selvavinayagam ST, et al. Among authors: byrareddy sn. Lancet Reg Health Southeast Asia. 2023 Sep 4;19:100272. doi: 10.1016/j.lansea.2023.100272. eCollection 2023 Dec. Lancet Reg Health Southeast Asia. 2023. PMID: 38076717 Free PMC article.
153 results